NSN 6505-01-695-6725 · NIIN 016956725 · FSC 6505
NO DASHES 6505016956725
In Stock
REMDESIVIR,INJECTION
Drugs and Biologicals
Technical characteristics
6 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CSGS | ADMINISTRATION | INTRAVENOUS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| FEAT | SPECIAL FEATURES | INDICATED FOR ADULTS AND PEDIATRIC PATIENTS (12 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 40 KG); FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) REQUIRING HOSPITALIZATION; THE LYOPHILIZED FORMULATION NEEDS TO BE RECONSTITUTED AND THEN DILUTED INTO NORMAL SALINE IV INFUSION FLUIDS PRIOR TO USE; THE LYOPHILIZED POWDER CAN BE STORED BELOW 86F (30C) PRIOR TO USE. AFTER RECONSTITUTION, USE VIALS IMMEDIATELY TO PREPARE DILUTED SOLUTION; THE DILUTED SOLUTION IN THE INFUSION BAGS CAN BE STORED UP TO 24 HOURS AT ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F) PRIOR TO ADMINISTRATION OR 48 HOURS AT REFRIGERATED TEMPERATURE 2 C TO 8 C (36 F TO 46 F); INTENDED FOR INTRAVENOUS ADMINISTRATION; SUPPLIED AS A SINGLE-DOSE VIAL CONTAINING A STERILE, PRESERVATIVE FREE WHITE TO OFF-WHITE TO YELLOW LYOPHILIZED POWDER; 100 MG; DISCARD UNUSED PORTION. |
| CQGK | SECONDARY CONTAINER TYPE | BOX |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | REMDESIVIR INJECTION, STERILE POWDER, 100MG VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLIGRAMS 100.0 |